Transitional angiogenesis and vascular remodeling during coronary angiogenesis in response to myocardial infarction

被引:11
作者
Grass, Taren M. [1 ]
Lurie, Diana I. [1 ]
Coffin, J. Douglas [1 ]
机构
[1] Univ Montana, Dept Biomed & Pharmaceut Sci, Ctr Environm Hlth Sci, Missoula, MT 59812 USA
关键词
coronary; angiogenesis; vascular; remodeling; infarct; LacZ; transgenic;
D O I
10.1016/j.acthis.2006.09.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Coronary artery disease (CAD) is a major source of morbidity and mortality in the industrialized world. CAD causes ischemia as a prelude to angina, myocardial infarction and heart failure as specific forms of heart disease causing a decline in the quality of life. CAD or atherosclerosis and the resulting myocardial ischemia trigger a natural angiogenic response that generates collateral. circulations. The long-term goat for these studies is to develop therapeutic angiogenesis that augments the natural coronary angiogenesis. This project makes use of an infarcted transgenic mouse model to characterize formation of those collateral circulations in the post-infraction heart. The experiments utilized thoracotomy and a microcauterizer to produce an infarct in transgenic mice and this stimulated neovascularization and allowed labeling of the coronary vessels, thereby defining the morphogenic processes involved in formation of collateral circulations. The results show that the heart consistently responds to infarcts with angiogenesis at 1 d post-treatment (PT) that undergoes transition into vascular remodeling at 7 d PT with complete remodeling at 14 d PT. The vascular remodeling appears to mitigate any net increase in perfusion that may be achieved early in coronary angiogenesis. The results suggest that therapeutic approaches need to shift from an exclusive focus on stimulating angiogenesis to include modulation of vascular remodeling for increased tong-term myocardial perfusion. (c) 2006 Elsevier GrnbH. All rights reserved.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 27 条
[1]
[Anonymous], 1994, MANIPULATING MOUSE E
[2]
Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine [J].
Arras, M ;
Strasser, R ;
Mohri, M ;
Doll, R ;
Eckert, P ;
Schaper, W ;
Schaper, J .
BASIC RESEARCH IN CARDIOLOGY, 1998, 93 (02) :97-107
[3]
Activation of myocardial angiogenesis and upregulation of fibroblast growth factor-2 in transmyocardial-revascularization-treated mice [J].
Chiotti, K ;
Choo, SJ ;
Martin, SL ;
Reichert, C ;
Grass, TM ;
Duran, CMG ;
Coffin, JD .
CORONARY ARTERY DISEASE, 2000, 11 (07) :537-544
[4]
Couffinhal T, 1998, AM J PATHOL, V152, P1667
[5]
Dimmeler S, 2000, CIRC RES, V87, P434
[6]
Frazier OH, 2004, TEX HEART I J, V31, P231
[7]
HOGAN B, 1994, TEX HEART I J
[8]
Immunohistologic labeling of murine endothelium [J].
Ismail, JA ;
Poppa, V ;
Kernper, LE ;
Scatena, M ;
Giachelli, CM ;
Coffin, JD ;
Murry, CE .
CARDIOVASCULAR PATHOLOGY, 2003, 12 (02) :82-90
[9]
Gene expression profile in mouse myocardium after ischemia [J].
Lyn, D ;
Liu, XW ;
Bennett, NA ;
Emmett, NL .
PHYSIOLOGICAL GENOMICS, 2000, 2 (03) :93-100